Senior Scientist, Analytical Development
enGene (NASDAQ: ENGN) is a late-stage biotechnology company mainstreaming genetic medicines through the delivery... are unresponsive to BCG. Detalimogene voraplasmid was developed using enGene's PROPRIETARY, Dually Derivatized Oligochitosan (DDX...
Lugar: Boston, MA | 08/01/2026 18:01:33 PM | Salario: S/. $150000 - 165000 per year | Empresa: enGene